Vanguard Group Inc Cara Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
A detailed history of Vanguard Group Inc transactions in Cara Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,481,258 shares of CARA stock, worth $645,127. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,481,258
Previous 2,631,067
5.69%
Holding current value
$645,127
Previous $1.95 Million
15.98%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CARA
# of Institutions
101Shares Held
21.5MCall Options Held
50KPut Options Held
0-
Black Rock Inc. New York, NY3.42MShares$889,5540.0% of portfolio
-
Disciplined Growth Investors Inc Minneapolis, MN1.82MShares$471,9150.03% of portfolio
-
Chescapmanager LLC Baltimore, MD1.7MShares$442,5480.15% of portfolio
-
Farallon Capital Management LLC San Francisco, CA1.56MShares$404,6250.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.33MShares$346,4440.0% of portfolio
About Cara Therapeutics, Inc.
- Ticker CARA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,725,900
- Market Cap $14M
- Description
- Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...